Help for those with COPD
2011-09-12
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Help for those with COPD
Alternative title
Authors
Published Date
2011-09-12
Publisher
Type
Audio
Abstract
Welcome to Public Health Moment from the University of Minnesota. Good news for those who suffer from chronic obstructive pulmonary disease – or COPD: A clinical trial involving more than 1,100 people has found that a common antibiotic called azithromycin can reduce the occurrence and severity of COPD exacerbations or flareups. COPD refers to a group of chronic lung diseases that block airflow. These include bronchitis and emphysema. Joining us today is professor John Connett, a University of Minnesota biostatistican, who led the study. John, can you explain how the study was conducted and summarize the key findings? It looks like there were some side effects, with loss of hearing being one of them. Can you talk about that? And what advice do you have for people who suffer from this? Any thing else you’d like to mention about this study? Thanks John. For Public Health Moment, I’m Mark Engebretson.
Keywords
Description
Runtime 1:30 minutes
This resource is provided for informational purposes only and may not reflect current scientific knowledge or medical recommendations.
This resource is provided for informational purposes only and may not reflect current scientific knowledge or medical recommendations.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Other identifiers
Suggested citation
Engebretson, Mark; John Connett. (2011). Help for those with COPD. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/257646.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.